Am­gen vet David Meline finds a new CFO roost at Mod­er­na, tak­ing a ride on the Covid-19 tiger as de­part­ing ex­ec cash­es out with $12M

We found out a few weeks ago that Mod­er­na CFO Lorence Kim isn’t wait­ing around to see how the biotech wun­derkind makes out in its fran­tic race to field a mes­sen­ger RNA vac­cine that can quell Covid-19. And now we know who’s step­ping on board to take his place in the lat­est move in the ex­ec­u­tive suite.

David Meline, who forged his rep dur­ing a 6-year run at Am­gen, slipped out the ex­it right af­ter his Q2 “re­tire­ment” par­ty in Cal­i­for­nia — pre­sum­ably vir­tu­al — and start­ed the next chap­ter of his ca­reer at a biotech com­pa­ny bet­ting big on rev­o­lu­tion­iz­ing the vac­cine R&D space.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER